BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28960140)

  • 1. An inter-domain regulatory mechanism controls toxic activities of PrP
    McDonald AJ; Wu B; Harris DA
    Prion; 2017 Nov; 11(6):388-397. PubMed ID: 28960140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N-terminus of the prion protein is a toxic effector regulated by the C-terminus.
    Wu B; McDonald AJ; Markham K; Rich CB; McHugh KP; Tatzelt J; Colby DW; Millhauser GL; Harris DA
    Elife; 2017 May; 6():. PubMed ID: 28527237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion neurotoxicity.
    Le NTT; Wu B; Harris DA
    Brain Pathol; 2019 Mar; 29(2):263-277. PubMed ID: 30588688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
    Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
    Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.
    Sonati T; Reimann RR; Falsig J; Baral PK; O'Connor T; Hornemann S; Yaganoglu S; Li B; Herrmann US; Wieland B; Swayampakula M; Rahman MH; Das D; Kav N; Riek R; Liberski PP; James MN; Aguzzi A
    Nature; 2013 Sep; 501(7465):102-6. PubMed ID: 23903654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion protein expression level alters regional copper, iron and zinc content in the mouse brain.
    Pushie MJ; Pickering IJ; Martin GR; Tsutsui S; Jirik FR; George GN
    Metallomics; 2011 Feb; 3(2):206-14. PubMed ID: 21264406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Peptide Aptamers with Prion Protein Central Domain Promotes α-Cleavage of PrP
    Corda E; Du X; Shim SY; Klein AN; Siltberg-Liberles J; Gilch S
    Mol Neurobiol; 2018 Oct; 55(10):7758-7774. PubMed ID: 29460268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
    Iraci N; Stincardini C; Barreca ML; Biasini E
    Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The charge structure of helix 1 in the prion protein regulates conversion to pathogenic PrPSc.
    Norstrom EM; Mastrianni JA
    J Virol; 2006 Sep; 80(17):8521-9. PubMed ID: 16912302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated but Not Deleted Ovine PrP(C) N-Terminal Polybasic Region Strongly Interferes with Prion Propagation in Transgenic Mice.
    Khalifé M; Reine F; Paquet-Fifield S; Castille J; Herzog L; Vilotte M; Moudjou M; Moazami-Goudarzi K; Makhzami S; Passet B; Andréoletti O; Vilette D; Laude H; Béringue V; Vilotte JL
    J Virol; 2016 Feb; 90(3):1638-46. PubMed ID: 26608316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic roles of the N-terminal domain of prion protein to doppel.
    Sakaguchi S
    Prion; 2008; 2(3):107-11. PubMed ID: 19158506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble polymorphic bank vole prion proteins induced by co-expression of quiescin sulfhydryl oxidase in E. coli and their aggregation behaviors.
    Abskharon R; Dang J; Elfarash A; Wang Z; Shen P; Zou LS; Hassan S; Wang F; Fujioka H; Steyaert J; Mulaj M; Surewicz WK; Castilla J; Wohlkonig A; Zou WQ
    Microb Cell Fact; 2017 Oct; 16(1):170. PubMed ID: 28978309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The compound (3-{5-[(2,5-dimethoxyphenyl)amino]-1,3,4-thiadiazolidin-2-yl}-5,8-methoxy-2H-chromen-2-one) inhibits the prion protein conversion from PrP
    Pagadala NS; Bjorndahl TC; Joyce M; Wishart DS; Syed K; Landi A
    Bioorg Med Chem; 2017 Oct; 25(20):5875-5888. PubMed ID: 28951092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking.
    Sakaguchi S; Uchiyama K
    Prion; 2017 Nov; 11(6):398-404. PubMed ID: 29099278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prion protein and copper: a mysterious relationship].
    Rachidi W; Riondel J; McMahon HM; Favier A
    Pathol Biol (Paris); 2005 May; 53(4):244-50. PubMed ID: 15850959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.